Androgen-Deprivation Therapy and the Risk of Stroke in Patients With Prostate Cancer

被引:95
作者
Azoulay, Laurent [1 ,2 ]
Yin, Hui [1 ]
Benayoun, Serge [3 ]
Renoux, Christel [1 ]
Boivin, Jean-Francois [1 ,4 ]
Suissa, Samy [1 ,4 ]
机构
[1] Sir Mortimer B Davis Jewish Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ, Canada
[3] Hop Maison Neuve Rosemont, Dept Urol, Montreal, PQ H1T 2M4, Canada
[4] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
Prostate; Androgen-deprivation therapy; Population based; Stroke; Cerebrovascular; PRACTICE RESEARCH DATABASE; CARDIOVASCULAR-DISEASE; SERUM TESTOSTERONE; HORMONE AGONIST; MEN; INFORMATION; VALIDATION; CESSATION;
D O I
10.1016/j.eururo.2011.08.041
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Background: Some evidence indicates that androgen-deprivation therapy (ADT) increases the risk of diabetes and cardiovascular disease. To date, few studies have investigated whether this therapy also increases the risk of cerebrovascular events. Objective: To determine whether different types of ADT increase the risk of stroke/transient ischaemic attacks (TIAs) in patients with prostate cancer. Design, setting, and participants: We conducted a population-based cohort study using a nested case-control analysis within the United Kingdom's General Practice Research Database population. The cohort included all patients at least 40 yr of age newly diagnosed with prostate cancer between January 1, 1988, and December 31, 2008, and followed until December 31, 2009. Cases consisted of those who experienced a first-ever stroke/TIA during follow-up. Up to 10 controls were matched to each case on age, year of cohort entry, and duration of follow-up. Measurements: Adjusted rate ratios (RRs) of stroke/TIA associated with the use of different ADTs (gonadotropin-releasing hormone [GnRH] agonists, oral antiandrogens, combined androgen blockade, bilateral orchiectomy, and others) were estimated using conditional logistic regression. Results and limitations: The cohort included 22 310 patients with prostate cancer, followed for a mean of 3.9 yr, where 938 patients experienced a first-ever stroke/TIA (rate: 10.7 per 1000/yr). Compared with nonusers of ADT, current users of GnRH agonists (adjusted RR: 1.18; 95% confidence interval [CI], 1.00-1.39), oral antiandrogens (adjusted RR: 1.47; 95% CI, 1.08-2.01), and those who underwent bilateral orchiectomy (adjusted RR: 1.77; 95% CI, 1.25-2.39) were at an increased risk of stroke/TIA. No statistically significant increased risks were observed for patients on combined androgen blockade and other ADTs, but the small numbers do not rule out a possible association. Conclusions: The results of this large population-based study provide additional evidence that different forms of ADT may increase the risk of stroke/TIA. (C) 2011 European Association of Urology. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1244 / 1250
页数:7
相关论文
共 23 条
[1]
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes [J].
Alibhai, Shabbir M. H. ;
Duong-Hua, Minh ;
Sutradhar, Rinku ;
Fleshner, Neil E. ;
Warde, Padraig ;
Cheung, Angela M. ;
Paszat, Lawrence F. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3452-3458
[2]
Serum testosterone recovery after cessation of long-term luteinizing hormone-releasing hormone agonist in patients with prostate cancer [J].
Bong, Gary W. ;
Clarke, Harry S., Jr. ;
Hancock, Wanda C. ;
Keane, Thomas E. .
UROLOGY, 2008, 71 (06) :1177-1180
[3]
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy [J].
Braga-Basaria, M. ;
Muller, D. C. ;
Carducci, M. A. ;
Dobs, A. S. ;
Basaria, S. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (05) :494-498
[4]
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy [J].
Braga-Basaria, Milena ;
Dobs, Adrian S. ;
Muller, Denis C. ;
Carducci, Michael A. ;
John, Majnu ;
Egan, Josephine ;
Basaria, Shehzad .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3979-3983
[5]
National practice patterns and time trends in androgen ablation for localized prostate cancer [J].
Cooperberg, MR ;
Grossfeld, GD ;
Lubeck, DP ;
Carroll, PR .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :981-989
[6]
Triptans in migraine - The risks of stroke, cardiovascular disease, and death in practice [J].
Hall, GC ;
Brown, MM ;
Mo, JP ;
MacRae, KD .
NEUROLOGY, 2004, 62 (04) :563-568
[7]
Huggins C, 1941, CANCER RES, V1, P293
[8]
VALIDATION OF INFORMATION RECORDED ON GENERAL-PRACTITIONER BASED COMPUTERIZED DATA RESOURCE IN THE UNITED-KINGDOM [J].
JICK, H ;
JICK, SS ;
DERBY, LE .
BRITISH MEDICAL JOURNAL, 1991, 302 (6779) :766-768
[9]
Calcium-channel blockers and risk of cancer [J].
Jick, H ;
Jick, S ;
Derby, LE ;
Vasilakis, C ;
Myers, MW ;
Meier, CR .
LANCET, 1997, 349 (9051) :525-528
[10]
Validity of the General Practice Research Database [J].
Jick, SS ;
Kaye, JA ;
Vasilakis-Scaramozza, C ;
Rodríguez, LAG ;
Ruigómez, A ;
Meier, CR ;
Schlienger, RG ;
Black, C ;
Jick, H .
PHARMACOTHERAPY, 2003, 23 (05) :686-689